Home » Newsletters » BioWorld Science

BioWorld Science

July 4, 2019

View Archived Issues

Their antiviral work done, T cells go rogue

Clinical qualification of a novel P2X7-specific PET ligand in healthy volunteers

Phase III trial of tucidinostat/exemestane in advanced, HR-positive breast cancer

Sirona's SGLT2 inhibitor TFC-039 advancing through phase I trials

Protein provides protection against diabetic retinopathy

ADAMTS13 deficiency contributes to Alzheimer's disease cerebrovascular dysfunction

Phase II trial of axitinib plus pembrolizumab in patients with advanced sarcomas

Entera initiates phase II dose ranging study for oral PTH

University of Dundee and Bukwang Pharmaceutical partner to develop new treatment for PD

BST-236 demonstrates promising safety in patients with AML unfit for standard therapy

CARMIL2 variant linked to infantile onset of colitis and gastrointestinal eosinophilic disease

miRNAs and angiogenic factors as potential new biomarkers in CML

miR-451 is a potential therapeutic target for spinocerebellar ataxia type 2 treatment

FDA grants IND approval to novel PD-1/VEGF bispecific antibody for solid tumors

[177Lu]BL-01 as a radiotherapeutic agent for CXCR4-expressing lymphoma

Confo Therapeutics and DyNAbind establish GPCR drug discovery collaboration

European Commission approves Ultomiris for adults with PNH

FDA grants accelerated approval to Xpovio for relapsed refractory multiple myeloma

Synergys Biotherapeutics receives NCI funding for development of anti-HER2 antibody fusion candidate

Leo Pharma patents PDE4 inhibitors

GlaxoSmithKline identifies new IDO1 inhibitors for HIV infection

New PRMT5 inhibitors for cancer presented by Lupin

Gedeon Richter divulges vasopressin V1A receptor antagonists

VenatoRx Pharmaceuticals synthesizes HBV capsid assembly modulators

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...